Pro Net Interest Income vs Selling And Marketing Expenses Analysis

PME Stock

251.89 3.71 1.49%

Pro Medicus financial indicator trend analysis is much more than just breaking down Pro Medicus prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Pro Medicus is a good investment. Please check the relationship between Pro Medicus Net Interest Income and its Selling And Marketing Expenses accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pro Medicus. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Net Interest Income vs Selling And Marketing Expenses

Net Interest Income vs Selling And Marketing Expenses Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Pro Medicus Net Interest Income account and Selling And Marketing Expenses. At this time, the significance of the direction appears to have very strong relationship.

The correlation between Pro Medicus' Net Interest Income and Selling And Marketing Expenses is 0.87. Overlapping area represents the amount of variation of Net Interest Income that can explain the historical movement of Selling And Marketing Expenses in the same time period over historical financial statements of Pro Medicus, assuming nothing else is changed. The correlation between historical values of Pro Medicus' Net Interest Income and Selling And Marketing Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Interest Income of Pro Medicus are associated (or correlated) with its Selling And Marketing Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Selling And Marketing Expenses has no effect on the direction of Net Interest Income i.e., Pro Medicus' Net Interest Income and Selling And Marketing Expenses go up and down completely randomly.

Correlation Coefficient

0.87

Relationship Direction	Positive
Relationship Strength	Strong

View All Relationships

Net Interest Income

The difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities.

Selling And Marketing Expenses

Most indicators from Pro Medicus' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Pro Medicus current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pro Medicus. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Selling General Administrative is likely to gain to about 31.9 M in 2024. Tax Provision is likely to gain to about 35.4 M in 2024

	2021	2022	2023	2024 (projected)
Total Operating Expenses	7.9M	8.5M	10.1M	9.6M
EBITDA	70.4M	94.1M	120.8M	126.8M

Total Operating Expenses Ebitda

Pro Medicus fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Common Stock	Other Liab	Other Assets
Total Assets		-0.63	0.75	0.99	1.0	-0.02	0.98	-0.87	0.99	0.93	0.89	0.96	0.99	0.99	0.75	0.79	0.94	-0.46	-0.93	0.98	-0.29	1.0	-0.22	0.82	0.95	0.02
Short Long Term Debt Total	-0.63		-0.1	-0.61	-0.62	0.06	-0.64	0.59	-0.61	-0.58	-0.61	-0.62	-0.64	-0.65	-0.35	-0.38	-0.64	0.32	0.76	-0.63	0.36	-0.64	0.54	-0.42	-0.63	-0.16
Other Current Liab	0.75	-0.1		0.77	0.74	-0.21	0.77	-0.65	0.73	0.69	0.66	0.65	0.73	0.76	0.72	0.7	0.74	-0.47	-0.51	0.76	-0.37	0.74	0.37	0.67	0.76	-0.02
Total Current Liabilities	0.99	-0.61	0.77		0.98	-0.03	0.97	-0.91	0.98	0.94	0.93	0.94	0.99	0.98	0.75	0.76	0.94	-0.45	-0.94	0.98	-0.26	0.99	-0.19	0.76	0.95	0.0
Total Stockholder Equity	1.0	-0.62	0.74	0.98		-0.01	0.97	-0.84	1.0	0.92	0.87	0.95	1.0	0.99	0.72	0.78	0.91	-0.41	-0.92	0.96	-0.28	1.0	-0.26	0.85	0.92	-0.02
Property Plant And Equipment Net	-0.02	0.06	-0.21	-0.03	-0.01		-0.05	0.09	0.0	0.0	-0.08	0.03	-0.02	-0.05	-0.26	-0.22	-0.06	0.24	-0.05	-0.05	0.29	-0.02	0.07	0.0	-0.12	-0.05
Current Deferred Revenue	0.98	-0.64	0.77	0.97	0.97	-0.05		-0.85	0.96	0.92	0.88	0.95	0.96	0.99	0.78	0.8	0.97	-0.55	-0.89	0.99	-0.37	0.97	-0.14	0.79	0.98	0.11
Net Debt	-0.87	0.59	-0.65	-0.91	-0.84	0.09	-0.85		-0.83	-0.79	-1.0	-0.85	-0.86	-0.87	-0.75	-0.63	-0.9	0.53	0.91	-0.92	0.23	-0.86	0.14	-0.45	-0.89	-0.23
Retained Earnings	0.99	-0.61	0.73	0.98	1.0	0.0	0.96	-0.83		0.92	0.85	0.93	1.0	0.98	0.69	0.77	0.89	-0.37	-0.92	0.94	-0.25	1.0	-0.28	0.86	0.9	-0.05
Accounts Payable	0.93	-0.58	0.69	0.94	0.92	0.0	0.92	-0.79	0.92		0.81	0.93	0.92	0.91	0.76	0.79	0.9	-0.42	-0.86	0.93	-0.21	0.92	-0.26	0.77	0.91	0.0
Cash	0.89	-0.61	0.66	0.93	0.87	-0.08	0.88	-1.0	0.85	0.81		0.87	0.88	0.89	0.75	0.67	0.91	-0.52	-0.93	0.93	-0.24	0.89	-0.16	0.49	0.9	0.22
Non Current Assets Total	0.96	-0.62	0.65	0.94	0.95	0.03	0.95	-0.85	0.93	0.93	0.87		0.94	0.95	0.81	0.8	0.95	-0.55	-0.92	0.96	-0.24	0.94	-0.29	0.75	0.95	0.15
Cash And Short Term Investments	0.99	-0.64	0.73	0.99	1.0	-0.02	0.96	-0.86	1.0	0.92	0.88	0.94		0.99	0.7	0.76	0.91	-0.38	-0.94	0.96	-0.27	1.0	-0.27	0.83	0.92	-0.03
Net Receivables	0.99	-0.65	0.76	0.98	0.99	-0.05	0.99	-0.87	0.98	0.91	0.89	0.95	0.99		0.75	0.78	0.95	-0.49	-0.92	0.98	-0.31	0.99	-0.2	0.8	0.96	0.04
Common Stock Total Equity	0.75	-0.35	0.72	0.75	0.72	-0.26	0.78	-0.75	0.69	0.76	0.75	0.81	0.7	0.75		0.82	0.85	-0.84	-0.63	0.81	-0.49	0.71	0.04	0.52	0.86	0.3
Common Stock Shares Outstanding	0.79	-0.38	0.7	0.76	0.78	-0.22	0.8	-0.63	0.77	0.79	0.67	0.8	0.76	0.78	0.82		0.78	-0.48	-0.62	0.79	-0.36	0.77	-0.1	0.7	0.81	0.11
Non Current Liabilities Total	0.94	-0.64	0.74	0.94	0.91	-0.06	0.97	-0.9	0.89	0.9	0.91	0.95	0.91	0.95	0.85	0.78		-0.65	-0.89	0.99	-0.38	0.92	-0.09	0.66	1.0	0.23
Inventory	-0.46	0.32	-0.47	-0.45	-0.41	0.24	-0.55	0.53	-0.37	-0.42	-0.52	-0.55	-0.38	-0.49	-0.84	-0.48	-0.65		0.38	-0.57	0.6	-0.41	-0.17	-0.22	-0.65	-0.5
Other Stockholder Equity	-0.93	0.76	-0.51	-0.94	-0.92	-0.05	-0.89	0.91	-0.92	-0.86	-0.93	-0.92	-0.94	-0.92	-0.63	-0.62	-0.89	0.38		-0.92	0.15	-0.94	0.43	-0.63	-0.87	-0.06
Total Liab	0.98	-0.63	0.76	0.98	0.96	-0.05	0.99	-0.92	0.94	0.93	0.93	0.96	0.96	0.98	0.81	0.79	0.99	-0.57	-0.92		-0.33	0.97	-0.14	0.71	0.99	0.13
Property Plant And Equipment Gross	-0.29	0.36	-0.37	-0.26	-0.28	0.29	-0.37	0.23	-0.25	-0.21	-0.24	-0.24	-0.27	-0.31	-0.49	-0.36	-0.38	0.6	0.15	-0.33		-0.28	-0.24	-0.32	-0.4	-0.28
Total Current Assets	1.0	-0.64	0.74	0.99	1.0	-0.02	0.97	-0.86	1.0	0.92	0.89	0.94	1.0	0.99	0.71	0.77	0.92	-0.41	-0.94	0.97	-0.28		-0.25	0.83	0.93	-0.02
Short Term Debt	-0.22	0.54	0.37	-0.19	-0.26	0.07	-0.14	0.14	-0.28	-0.26	-0.16	-0.29	-0.27	-0.2	0.04	-0.1	-0.09	-0.17	0.43	-0.14	-0.24	-0.25		-0.22	-0.08	0.15
Common Stock	0.82	-0.42	0.67	0.76	0.85	0.0	0.79	-0.45	0.86	0.77	0.49	0.75	0.83	0.8	0.52	0.7	0.66	-0.22	-0.63	0.71	-0.32	0.83	-0.22		0.69	-0.16
Other Liab	0.95	-0.63	0.76	0.95	0.92	-0.12	0.98	-0.89	0.9	0.91	0.9	0.95	0.92	0.96	0.86	0.81	1.0	-0.65	-0.87	0.99	-0.4	0.93	-0.08	0.69		0.21
Other Assets	0.02	-0.16	-0.02	0.0	-0.02	-0.05	0.11	-0.23	-0.05	0.0	0.22	0.15	-0.03	0.04	0.3	0.11	0.23	-0.5	-0.06	0.13	-0.28	-0.02	0.15	-0.16	0.21

Click cells to compare fundamentals

Pro Medicus Account Relationship Matchups

Pro Medicus fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	95.6M	125.6M	157.1M	202.1M	257.4M	270.3M
Short Long Term Debt Total	2.3M	2.6M	2.3M	1.9M	2.1M	1.8M
Other Current Liab	4.1M	5.6M	8.2M	10.0M	12.8M	13.5M
Total Current Liabilities	12.7M	17.6M	26.9M	30.9M	34.6M	36.3M
Total Stockholder Equity	60.2M	81.7M	101.7M	138.8M	187.7M	197.1M
Property Plant And Equipment Net	2.8M	3.0M	2.6M	2.2M	2.4M	3.0M
Current Deferred Revenue	7.2M	8.9M	10.1M	12.6M	17.1M	17.9M
Net Debt	(41.1M)	(39.4M)	(61.4M)	(89.4M)	(58.0M)	(55.1M)
Retained Earnings	49.6M	66.9M	92.6M	127.1M	173.4M	182.0M
Accounts Payable	835K	872K	1.6M	1.0M	1.7M	1.8M
Cash	43.4M	42.0M	63.7M	91.2M	60.1M	63.1M
Non Current Assets Total	34.2M	38.0M	37.2M	38.3M	50.9M	53.4M
Cash And Short Term Investments	43.4M	61.8M	90.6M	121.5M	155.4M	163.2M
Net Receivables	17.0M	24.4M	27.4M	40.7M	49.2M	51.7M
Common Stock Shares Outstanding	104.5M	104.6M	104.6M	104.6M	104.7M	111.9M
Liabilities And Stockholders Equity	95.6M	125.6M	157.1M	202.1M	257.4M	270.3M
Non Current Liabilities Total	22.7M	26.3M	28.5M	32.5M	35.1M	36.9M
Inventory	35K	34K	77K	55K	49K	75.3K
Other Stockholder Equity	(51.6M)	(68.9M)	(94.5M)	(129.1M)	(116.2M)	(110.4M)
Total Liab	35.5M	43.9M	55.3M	63.4M	69.7M	73.2M
Property Plant And Equipment Gross	2.8M	6.9M	6.3M	6.3M	2.4M	2.3M
Total Current Assets	61.5M	87.6M	119.8M	163.8M	206.6M	216.9M
Accumulated Other Comprehensive Income	8.6M	12.8M	7.2M	9.7M	(9.3M)	(8.8M)
Short Term Debt	522K	574K	604K	1.4M	553K	525.4K
Other Liab	21.0M	24.2M	26.8M	31.3M	36.0M	37.8M
Other Assets	9.4M	13.2M	40.5M	1.0	12.4M	0.95
Other Current Assets	1.0M	1.3M	1.8M	1.6M	1.9M	950.4K
Property Plant Equipment	2.8M	3.0M	2.6M	2.2M	2.5M	2.6M
Non Currrent Assets Other	237K	30.0K	(1.0)	242K	40K	42K
Intangible Assets	18.8M	20.0M	22.3M	21.3M	20.1M	10.2M
Net Tangible Assets	41.3M	61.7M	79.4M	117.4M	135.0M	141.8M
Long Term Debt Total	1.8M	2.0M	1.7M	1.2M	1.4M	1.0M
Net Invested Capital	60.2M	81.7M	101.7M	138.8M	187.7M	96.2M
Net Working Capital	48.8M	69.9M	93.0M	132.9M	172.0M	180.6M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Pro Stock Analysis

When running Pro Medicus' price analysis, check to measure Pro Medicus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pro Medicus is operating at the current time. Most of Pro Medicus' value examination focuses on studying past and present price action to predict the probability of Pro Medicus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pro Medicus' price. Additionally, you may evaluate how the addition of Pro Medicus to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC